(Q63575823)
Statements
Clinical Efficacy of Topical Hydrocortisone 0.335% (Softacort®) in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation (English)
0 references
27 March 2018
0 references
12 April 2019
0 references
60
0 references
18 year
0 references